Cargando…

Skin and skin structure infections: treatment with newer generation fluoroquinolones

Skin and skin structure infections (SSSI) are an emerging issue in healthcare. They are responsible for increasing heathcare utilization, both in hospitalizations and intravenous antibiotic use. SSSI are caused by an evolving variety of pathogens, including Gram-positive, Gram-negative, and anaerobi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giordano, Philip, Weber, Kurt, Gesin, Gail, Kubert, Jason
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2007
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936312/ https://www.ncbi.nlm.nih.gov/pubmed/18360639

Ejemplares similares

Newer fluoroquinolones in the treatment of acute exacerbations of COPD
por: Patel, Amit, et al.
Publicado: (2006)

Newer Topical Treatments in Skin and Nail Dermatophyte Infections
por: Sahni, Kanika, et al.
Publicado: (2018)

Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
por: Jones, Travis M, et al.
Publicado: (2016)

Moxifloxacin in the treatment of skin and skin structure infections
por: Guay, David RP
Publicado: (2006)

In the Quest of Drugs for Bad Bugs: Are Newer Fluoroquinolones Any Better?
por: Deep, Antariksh, et al.
Publicado: (2011)

Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
por: Leong, Hoe Nam, et al.
Publicado: (2018)

Notes on Some of the Newer Remedies Used in Diseases of the Skin
Publicado: (1897)

Role of telavancin in treatment of skin and skin structure infections
por: Bonkowski, Joseph, et al.
Publicado: (2010)

Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
por: Giordano, Philip A, et al.
Publicado: (2019)

2754. Delafloxacin and Comparator Fluoroquinolone In Vitro Resistance Trends in Isolates from Skin and Skin Structure Infections in the USA (2017–2022)
por: Carvalhaes, Cecilia G, et al.
Publicado: (2023)

Ceftaroline in complicated skin and skin-structure infections
por: Hernandez, Paul O, et al.
Publicado: (2012)

Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections
por: Townsend, Mary L, et al.
Publicado: (2007)

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
por: Ferrández, Olivia, et al.
Publicado: (2016)

A prescription event monitoring study on the utility of garenoxacin, a newer fluoroquinolone in India
por: Hajare, Anoop, et al.
Publicado: (2015)

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
por: Dunne, Michael W., et al.
Publicado: (2016)

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
por: Dunbar, Lala M, et al.
Publicado: (2008)

A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections
por: Shoemaker, D Matthew, et al.
Publicado: (2006)

Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review
por: Kmeid, Joumana, et al.
Publicado: (2015)

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
por: Leuthner, Kimberly D, et al.
Publicado: (2016)

Mini-Punch Skin Excision: A Newer Novel Approach for Tattoo Removal
por: Gupta, Jyoti, et al.
Publicado: (2019)

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
por: Hall, Ronald G, et al.
Publicado: (2015)

Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
por: Righi, Elda, et al.
Publicado: (2018)

Newer treatments for fibromyalgia syndrome
por: Harris, Richard E, et al.
Publicado: (2008)

Current Treatment Options for Acute Skin and Skin-structure Infections
por: Golan, Yoav
Publicado: (2019)

Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole
por: Barbour, April, et al.
Publicado: (2010)

New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
por: Juul, Janelle J, et al.
Publicado: (2016)

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli
por: Rattanaumpawan, Pinyo, et al.
Publicado: (2017)

Newer treatments for advanced hepatocellular carcinoma
por: Song, Myeong Jun, et al.
Publicado: (2014)

Newer-Generation Antidepressants and Suicide Risk
por: Hayes, Joseph F., et al.
Publicado: (2019)

In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections
por: McCurdy, S., et al.
Publicado: (2017)

New developments in the management of severe skin and deep skin structure infections – focus on tedizolid
por: Durkin, Michael J, et al.
Publicado: (2015)

Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy
por: Bassetti, Matteo, et al.
Publicado: (2019)

Newer Treatment Modalities in Epidermolysis Bullosa
por: Bruckner-Tuderman, Leena
Publicado: (2019)

Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline
por: Bidell, Monique R., et al.
Publicado: (2021)

Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting
por: Quirke, Michael, et al.
Publicado: (2015)

Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?
por: Le, Tri, et al.
Publicado: (2019)

Omadacycline for Acute Bacterial Skin and Skin Structure Infections
por: Abrahamian, Fredrick M, et al.
Publicado: (2019)

Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
por: Corey, G Ralph, et al.
Publicado: (2019)

Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?
por: Kujath, P, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_a8ls6n95ipsjro8lbe7gv666pn